The global biosimulation market size was valued at USD 3.5 billion in 2023, with Europe holding a significant market share. The market is driven by technological advancements in biosimulation platforms and tools, which enable efficient drug development and personalized medicine. It is projected to grow at a CAGR of 16.90% during the forecast period